Swiss prosecutors will not pursue Novartis over Trump lawyer payments
Novartis admitted that it had signed a one-year contract with the company of Trump’s private lawyer, Michael Cohen.
Keystone
The Office of the Attorney General of Switzerland (OAG) announced on Wednesday that it will not bring proceedings against Novartis in connection with the payments the Swiss pharmaceutical company made to Donald Trump’s personal lawyer.
This content was published on
1 minute
SDA-ATS/ln
The OAGExternal link had received a criminal complaint alleging that Novartis had bribed a foreign public official by paying CHF1.2 million ($1.2 million) to Trump’s lawyer Michael Cohen in 2017.
Novartis admitted in May that it had signed a one-year contract with the company of Trump’s private lawyer to gain insights into the US administration’s thinking on healthcare issues. The company used the same bank account for the payments that was also used in the Stormy Daniels case.
The OAG said it would not open criminal proceedings against the company because there was not sufficient evidence of bribery. The payments could not be linked to a breach of duty on the part of the recipient, therefore the conditions for Novartis’ criminal liability were not fulfilled.
The offence of undue influence does not exist in Swiss law.
The OAG said it would reserve the right to re-examine the situation should new evidence emerge.
More
More
Greek politicians named in Novartis scandal
This content was published on
Greece’s parliament has linked ten prominent politicians to a bribery scandal involving Swiss drug-maker Novartis.
Trump tariffs: Swiss brands struggle to adapt to 39% tariff
This content was published on
Swiss brands like Victorinox, the manufacturer of the iconic pocket knife, are struggling to adapt to the 39% tariff imposed by the United States on imports of Swiss goods.
Fish and aquatic plants are under ‘severe pressure’ in Swiss rivers and lakes
This content was published on
Fish, aquatic plants and other animals in Swiss rivers, lakes and streams remain under 'severe pressure', according to the Federal Office for the Environment.
Swatch withdraws ‘slanted eyes’ ad after China uproar
This content was published on
The Swiss watch manufacturer Swatch has apologised and withdrawn an advertising campaign worldwide following accusations of racism in China. The ad features a model pulling the corners of his eyes.
Police identify bodies of three climbers who died in Swiss Alps
This content was published on
Police have formally identified the bodies of three climbers who died in the Upper Valais region in early August: they are from Germany, France and Austria.
Bern exhibition reunites Kirchner paintings after 92 years
This content was published on
The painting Sonntag der Bergbauern (Alpsonntag) [Sunday of the Mountain Farmers (Alp Sunday) by Ernst Ludwig Kirchner (1880-1938) is being transferred from Berlin to Bern to feature in an upcoming exhibition at Kunstmuseum Bern.
Voters approve extension of Engadine Airport in Switzerland
This content was published on
Residents in the Upper Engadine region gave the greenlight on Sunday to the expansion of the regional airport at Samedan, one of Europe’s highest airports (1,707 metres) that serves the nearby resorts of St Moritz and Davos.
Private equity group Advent to buy U-Blox for $1.3 billion
This content was published on
Private equity group Advent International has agreed to take over Switzerland's U-Blox Holding in a cash offer worth CHF1.05 billion ($1.30 billion).
Trump made direct financial demands during call with Swiss president
This content was published on
During the telephone call between Karin Keller-Sutter and Donald Trump on July 31, Trump demanded direct payments from Switzerland, according to an investigation by SonntagsBlick.
Demonstrators in Swiss capital demand better access to mental health care
This content was published on
Thousands of people demonstrated in Berne on Saturday afternoon against long waiting lists, the lack of therapy places and the absence of a clear pricing structure.
This content was published on
Swiss companies' expectations for salary growth are down by 0.3 percentage points compared to a year ago, according to a survey conducted by the Center for Economic Research (KOF).
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Wanted: Pharma super cops
This content was published on
Have experience in tackling cybercrime, extremism, extortion, blackmail and bribery? If yes, the Swiss pharma industry might want to hear from you.
This content was published on
The Swiss pharmaceutical giant Novartis has announced that it plans to cut 500 jobs at its Basel headquarters in Switzerland over the next 18 months.
This content was published on
The company formed when Ciba Geigy and Sandoz merged and analysts say it’s a big success. The merger cost around 10,000 jobs but in the long-run more were created. The current CEO concedes that the merger also meant the loss of the Ciba corporate identity. Novartis’ profits shrank by a third in 2015, partly because…
Terrorism and financial crimes keep Attorney General busy
This content was published on
The Swiss Attorney General took on 237 new investigations in 2017, mainly linked to international economic crimes and terrorism.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.